Table 1

Comparison at baseline of treatment and control group, both with an apnoea/hypopnoea index ≥15

Treatment groupControl groupp-;value
Patients n3128
Age yrs
 Mean78.1±6.476.8±7.90.504
 Range61–8952–86
Sex
 Female17150.922
 Male14130.922
BMI kg·m−224.5±4.124.8±4.80.798
Previous stroke
 Cerebral infarction12110.964
 Intracerebral haemorrhage111.000
Current stroke
 Cerebral infarction28230.458
  Thrombotic infarction15150.691
  Embolic infarction1380.284
 Intracerebral haemorrhage350.458
Neurological impairment
 Hemiparesis left13160.243
 Hemiparesis right15190.205
 Aphasia350.458
 Facial palsy left990.795
 Facial palsy right750.653
Concurrent diseases
 Ischaemic heart disease23190.592
 Cardiac arrhythmias21130.098
 Congestive heart failure18160.943
 Hypertension20170.763
 Diabetes mellitus10120.401
 COPD040.045
 Previous diagnosed dementia111.000
 Faecal incontinence9100.583
 Urinary incontinence16150.880
 Indwelling urinary catheter660.843
Outcome variables
 Delirium22240.172
 MADRS21.0±10.420.5±11.90.860
 MMSE16.6±7.415.4±8.90.582
 Barthel-ADL index8.4±6.27.5±6.00.594
  • Data are presented as number (n), range or mean±sd

  • BMI: body mass index

  • COPD: chronic obstruction pulmonary disease

  • MADRS: Montgomery-Åsberg Depression Rating Scale

  • MMSE: Mini-Mental State Examination

  • ADL: activities of daily living